The Directorate of Drugs Control Punjab has issued a most urgent recall alert for Erizine 10mg Tablets after declaring a specific batch substandard.
Erizine 10mg contains Cetirizine Dihydrochloride and is commonly used to treat allergy symptoms such as sneezing, a runny nose and itchy eyes.
The directorate said the Drug Testing Laboratory Punjab found the batch substandard, after which the Provincial Quality Control Board ordered its immediate recall from the market.
The marketing authorisation holder has been directed to launch a nationwide recall without delay.
Retailers, pharmacies, medical stores, wholesalers, distributors and healthcare facilities have also been instructed to stop dispensing the affected batch immediately and report their stock and consumption records to the relevant drug inspector.
The directorate has asked all drug field formations across Punjab to tighten surveillance across the pharmaceutical supply chain and take action under the Drugs Act, 1976, the DRAP Act, 2012 and relevant rules.
Authorities have also been told to ensure full traceability of the recalled product and submit a detailed report to the Chief Drugs Controller Punjab.
Consumers and patients have been advised to stop using the affected batch at once, as the substandard medicine may pose a health risk.
The post Punjab Orders Recall Of Erizine Tablets appeared first on ProPakistani.